Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Wildemann

Showing results (61-70 of 204) with videos related to

Pageof 21
Sort By:
Plos One|October 25, 2013
Kinetics of IL-6 production defines T effector cell responsiveness to regulatory T cells in multiple sclerosisBettina Trinschek, Felix Luessi, Felix Lüssi, et al.
Journal of Neurology|October 7, 2021
COVID-19-related severe MS exacerbation with life-threatening Takotsubo cardiomyopathy in a previously stable patient and interference of MS therapy with long-term immunity against SARS-CoV-2Brigitte Wildemann, Sven Jarius, Lorenz H Lehmann, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|June 10, 2009
Disgust and fear recognition in paraneoplastic limbic encephalitisReiner Sprengelmeyer, Anthony P Atkinson, Anke Sprengelmeyer, et al.
Scientific Reports|August 11, 2016
Sodium MRI in Multiple Sclerosis is Compatible with Intracellular Sodium Accumulation and Inflammation-Induced Hyper-Cellularity of Acute Brain LesionsArmin Biller, Isabella Pflugmann, Stephanie Badde, et al.
Investigative Radiology|August 17, 2022
Peripheral Nerve Involvement at First Diagnosis of Multiple Sclerosis: A Prospective MR Neurography StudyOlivia Foesleitner, Laura Bettina Jäger, Daniel Schwarz, et al.
Archives of Neurology|November 13, 2008
Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cellsMirjam Korporal, Juergen Haas, Bettina Balint, et al.
Frontiers in Immunology|June 20, 2019
Alemtuzumab in Multiple Sclerosis: Short- and Long-Term Effects of Immunodepletion on the Peripheral Treg CompartmentJürgen Haas, Cornelia Würthwein, Mirjam Korporal-Kuhnke, et al.
Journal of Neuroimmunology|January 21, 2014
Anti-Ca/anti-ARHGAP26 antibodies associated with cerebellar atrophy and cognitive declineSarah Doss, Astrid Nümann, Annerose Ziegler, et al.
Frontiers in Neurology|May 20, 2024
Evolution of peripheral nerve changes in early multiple sclerosis-a longitudinal MR neurography studyOlivia Foesleitner, Jennifer C Hayes, Markus Weiler, et al.
Neurological Research and Practice|November 23, 2020
German guidelines on the diagnosis and treatment of neurosyphilisMatthias Klein, Klemens Angstwurm, Stefan Esser, et al.
Pageof 21

Showing results (61-70 of 204) with videos related to

Sort By:
Pageof 21
Plos One|October 25, 2013
Kinetics of IL-6 production defines T effector cell responsiveness to regulatory T cells in multiple sclerosisBettina Trinschek, Felix Luessi, Felix Lüssi, et al.
Journal of Neurology|October 7, 2021
COVID-19-related severe MS exacerbation with life-threatening Takotsubo cardiomyopathy in a previously stable patient and interference of MS therapy with long-term immunity against SARS-CoV-2Brigitte Wildemann, Sven Jarius, Lorenz H Lehmann, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|June 10, 2009
Disgust and fear recognition in paraneoplastic limbic encephalitisReiner Sprengelmeyer, Anthony P Atkinson, Anke Sprengelmeyer, et al.
Scientific Reports|August 11, 2016
Sodium MRI in Multiple Sclerosis is Compatible with Intracellular Sodium Accumulation and Inflammation-Induced Hyper-Cellularity of Acute Brain LesionsArmin Biller, Isabella Pflugmann, Stephanie Badde, et al.
Investigative Radiology|August 17, 2022
Peripheral Nerve Involvement at First Diagnosis of Multiple Sclerosis: A Prospective MR Neurography StudyOlivia Foesleitner, Laura Bettina Jäger, Daniel Schwarz, et al.
Archives of Neurology|November 13, 2008
Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cellsMirjam Korporal, Juergen Haas, Bettina Balint, et al.
Frontiers in Immunology|June 20, 2019
Alemtuzumab in Multiple Sclerosis: Short- and Long-Term Effects of Immunodepletion on the Peripheral Treg CompartmentJürgen Haas, Cornelia Würthwein, Mirjam Korporal-Kuhnke, et al.
Journal of Neuroimmunology|January 21, 2014
Anti-Ca/anti-ARHGAP26 antibodies associated with cerebellar atrophy and cognitive declineSarah Doss, Astrid Nümann, Annerose Ziegler, et al.
Frontiers in Neurology|May 20, 2024
Evolution of peripheral nerve changes in early multiple sclerosis-a longitudinal MR neurography studyOlivia Foesleitner, Jennifer C Hayes, Markus Weiler, et al.
Neurological Research and Practice|November 23, 2020
German guidelines on the diagnosis and treatment of neurosyphilisMatthias Klein, Klemens Angstwurm, Stefan Esser, et al.
Pageof 21